Floatz logo

AUTOLOGOUS CD34+ CELLS ENCODING .BETA.A-T87Q-GLOBIN GENE

Multiple Myeloma

CelgeneCell therapyDormant
D
26/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
59/ 100

Competitive context

344 Active assets in the Multiple Myeloma cohort.

Asset / SponsorPhaseRating
PREDNISONE TABLETS
GlaxoSmithKline
Phase 4BB
Thalidomide
Institute of Hematology & Blood Diseases Hospital, China
Phase 4BB
Inno-206
GlaxoSmithKline
Phase 4BB
CIS-DIAMMINEDICHLOROPLATINUM II
Janssen Research & Development, LLC
Phase 4BB
cc-5013
Universitätsklinikum Hamburg-Eppendorf
Phase 4BB

View all 50 →

Same molecule, other indications

AUTOLOGOUS CD34+ CELLS ENCODING .BETA.A-T87Q-GLOBIN GENE is also rated in:

beta thalassemiaDormant
B
Indicative ·
60 / 100
View asset →
beta-thalassemia majorDormant
CCC
Indicative ·
55 / 100
View asset →
Transfusion-dependent Beta-ThalassemiaDormant
CCC
Indicative ·
55 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →